Clinical Trial Update: Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD) [Phase 4]

View source ↗

Summary

This Clinical Trials update describes a Phase 4 study evaluating whether insulin glargine can improve myocardial function in patients with type 2 diabetes and c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine) (insulin glargine)

Snippet

Sponsor: Munich Municipal Hospital | Conditions: Coronary Artery Disease, Type 2 Diabetes | Phase 4 | Status: UNKNOWN